On November 14, 2026, with only days to go before Anthropic's planned November 19 listing, chief executive Dario Amodei told a JPMorgan investor event in New York: "There's a huge uncertainty in what's going to happen next year." He called compute "the deepest business dilemma that the company faces" — technology is advancing so fast that nobody knows how today's spending will translate into future revenue, yet compute has to be bought one to two years in advance.
Buying too much or too little are both bets
Amodei laid out both sides of the dilemma. Buy too little, and there are no resources when customers need them and new technology needs to ship, so revenue takes a hit. Buy too much, and cash gets locked into long-term contracts — "you can financially overextend yourself." Bloomberg reports that Anthropic has already committed nearly $901 billion in spending, most of it on compute and chips, with roughly $71 billion coming due by September 2027 — a figure that exceeds the market value of about two-thirds of S&P 500 companies. Back in February 2026, Amodei had warned of an even starker scenario: buying $1 trillion of compute starting at the end of 2027 could bankrupt the company if revenue fell short, and being off by just one year could be fatal. He added that he is not sure some competitors have really done the math.
The three cushions he named
Against that gamble, Amodei listed three cushions: the company's gross margins are "quite good," it holds a large cash balance, and it is raising more through the listing; on purchasing, it signs as little long-term prepayment as possible and tops up from the spot market — a strategy he compared to "buying insurance," covered if results fall short and able to invest more if business beats expectations. The compute bill laid bare on the eve of the listing is the core reason for going public: Anthropic plans to raise up to $64.4 billion through the IPO plus another $26 billion in a private placement, which together would make it the largest listing in history, and the offering is reportedly already about six times oversubscribed. The company's annualized revenue run rate reached $81 billion at the end of October, up $10 billion from late September.
What remains before pricing day
Pricing is set for November 18, with trading to begin on November 19. Amodei sounded relaxed about the timing, saying he was not fixated on any particular month. In the same conversation, he said he hopes AI will cure cancer and Alzheimer's within five to 15 years — while admitting he cannot be sure about that either. The compute commitments in the prospectus keep growing, and the market will soon answer with its subscription: whether investors are willing to pay for this uncertainty.
